Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,282 public trials 1,199 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC

NCT06552234

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • CH Aix-en-Provence Aix-en-Provence, Bouches Du Rhône, France
  • AP-HM Marseille, Bouches Du Rhône, France
  • HIA Sainte Anne Toulon, Var, France
  • CHU Angers Angers, France
View all 20 locations
View Trial Details
Recruiting

A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy

NCT06931717

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Wien AKH Vienna, Austria
  • North Estonia Medical Centre Foundation Talinn, Estonia
  • CHU d'Angers Angers, France
  • Centre hospitalier d'Avignon Avignon, France
View all 35 locations
View Trial Details
Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

NCT07300150

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +24 more
Locations
  • Dana-Farber/Massachusetts General Hospital, Inc Boston, Massachusetts, United States
  • New Experimental Therapeutics of San Antonio LLC San Antonio, Texas, United States
  • START - South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View Trial Details
Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • START New York Long Island Lake Success, New York, United States
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Genital Diseases, +28 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details

Related conditions